Mitochondria, Exercise and Metabolic Health: What We Know

Deck — Exercise is the best-studied lever on cellular machinery. What human trials show, where the evidence stops, and why “mitochondrial optimisation” promises usually outrun it.

Author: [EDITOR NAME] — Reviewer: [PENDING, must be a genuine, qualified reviewer] — Publication date: [DATE] — Last update: [DATE] — Scientific review: [DATE]

The three things worth taking away

• Trials in living humans show weeks of regular exercise raise measurable muscle-mitochondrial capacity and insulin sensitivity in young and older adults alike.
• Gains track your starting point more than your training style — moderate, interval and sprint work gave similar averaged increases.
• Administered MOTS-c rests on animal data and early human signals; the FDA flags safety unknowns for compounded MOTS-c.

Table of contents

1. Where your cells get their energy
2. What exercise actually changes in mitochondria
3. Metabolic flexibility
4. Where the evidence becomes thin
5. Why “mitochondrial optimisation” is usually an overclaim
6. Where MOTS-c research fits in
7. Known limitations
8. FAQ

1. Where your cells get their energy

Every cell runs on ATP, the energy currency that powers muscles, nerves and repair work. Mitochondria are the compartments where most of that ATP is made when oxygen is available: fuels such as glucose and fat feed chemical pathways that couple combustion to ATP production. Skeletal muscle leans on this system heavily; researchers studying type 2 diabetes note how strongly muscle depends on oxidative phosphorylation for its energy [1].

Two ideas matter for what follows. Capacity: how much oxidative work a muscle fibre can support before fatigue sets in. And signalling: reviews of exercise metabolism emphasise the molecular messaging that carries work and stress back into the cell’s own machinery [2] — the reason a peptide made inside mitochondria (MOTS-c, section 6) became a research story at all.

2. What exercise actually changes in mitochondria

In 1967, John Holloszy published the classic demonstration that endurance training increases a muscle’s mitochondrial respiratory capacity [3]. Six decades of human work have refined the picture considerably.

In a small, careful trial, eight sedentary men cycled daily for two weeks: within a week, mitochondrial markers — cytochrome c, COXIV and citrate synthase activity — had risen, and average peak oxygen uptake improved by about 17.5%. Notably, muscle mitochondrial-DNA copy number had not moved by the end [4]. Markers of the same phenomenon move on different clocks.

The most complete synthesis to date pooled training studies covering 5,973 participants. Averaged mitochondrial-content markers rose by roughly a quarter — about 23% with moderate continuous training and 27% with high-intensity interval or sprint-interval styles, statistically indistinguishable. Higher frequency predicted larger gains, lower starting fitness meant bigger percentage gains, and the capacity to adapt was maintained throughout life, in disease and in both sexes [5]. One trial is worth a full card:

Study summary — Robinson et al., 2017

• Design and participants: 12 weeks of supervised training in one of three modes — high-intensity aerobic intervals (HIIT), resistance training, or combined moderate aerobic-and-resistance work — in healthy adults aged 18–30 and 65–80, balanced by sex; the older cohort also completed a 12-week sedentary period before its combined-training phase.
• Finding: all modes enhanced insulin sensitivity and lean mass; only the aerobic-containing modes improved aerobic capacity and mitochondrial respiration (biopsied), with peak oxygen uptake up roughly 17–28%.
• Limitations: single centre; healthy volunteers; 12-week horizon; measurements 72 hours after the final session (durability untested); adverse events not reported.
• Funding and citation: US National Institutes of Health and Mayo Foundation; no declared conflicts. Robinson MM et al., Cell Metabolism 2017;25(3):581–592. doi:10.1016/j.cmet.2017.02.009 [6]

That connects to today’s medication debates: for lean mass and body composition, see our explainer (07).

3. Metabolic flexibility: the fuel-switching idea

Metabolic flexibility is the ability to shift fuel use with demand — more fat across long quiet stretches, more carbohydrate as intensity climbs. Reviews of the field describe obesity and type 2 diabetes as states of metabolic inflexibility [7].

The mitochondrial link is observational. In one biopsy study, muscle from people with type 2 diabetes showed lower respiratory-chain capacity, lower citrate synthase activity and smaller mitochondria than muscle from lean adults [1]. Ten people per group, cross-sectional — an association, not proven causation, and no promise that any individual would match the group average.

The interventional half is the trial above, where insulin sensitivity improved in all three modes, younger and older adults alike [6]. Observation identifies a difference associated with disease; trials show exercise moves the measured outcomes. That two-step is the standard every product promise in this space should face.

4. Where the evidence becomes thin

Human mitochondria are hard to measure. Most data come from needle biopsies of a single thigh muscle, which caps sample sizes; whole-body measures such as VO2max are proxies, not windows into anyone’s cells [4][5].

The markers also disagree in informative ways. Citrate synthase rose in the two-week trial while mitochondrial-DNA copy number did not [4]; in the synthesis, capillary adaptations arrived early in untrained participants while mitochondrial content kept responding over weeks [5]. There is no single number that captures “your mitochondria” — and marker choice changes the answer, a caution our evidence guide and study-reading toolkit (02) develop at length.

The boldest outcome data are observational too. In 122,007 treadmill-test referrals, risk-adjusted all-cause mortality fell with fitness — fittest versus least-fit hazard ratio 0.20, with “no observed upper limit of benefit” [8]. A strong single-centre association, not proof of cause in individuals.

And clinical guidance is behavioural, not mitochondrial: WHO 2020 recommends 150–300 weekly minutes of moderate (or 75–150 of vigorous) aerobic activity, regular muscle-strengthening activity and less sedentary time, with the message that some activity is better than none [9]. The guidelines target behaviour and health outcomes, not a mitochondrial score.

5. Why “mitochondrial optimisation” is usually an overclaim

“Optimise your mitochondria” implies a dial and an ideal setting. The field’s reality differs on three counts.

First, no validated metric exists. Researchers measure several imperfect, partially independent markers — enzyme activities, biopsied respiration, DNA copy numbers — that move on different clocks, sometimes in opposite directions [4][5]. A product selling “optimisation” is selling a precision the field’s measurement vocabulary does not possess.

Second, marker change is not outcome proof. The honest chain runs mechanism → marker movement → a human outcome tested and improved. Exercise has walked it for insulin sensitivity and aerobic capacity [6]; most commercial claims start at the mechanism and stop at the marketing.

Third, the baseline story is humbler: the largest gains went to the least fit, and adaptation stayed available across life and disease [5]. The fair summary is modest but strong — regular exercise, in several styles and at any starting age, measurably raises muscle-mitochondrial markers and insulin sensitivity in humans. Every other claim in this field auditions against that standard, most with a far thinner CV.

6. Where MOTS-c research fits in

MOTS-c is a 16-amino-acid peptide encoded in a short stretch of mitochondrial RNA — a reason researchers treat mitochondria as signalling organs, not just furnaces [10]. In mice, injected MOTS-c prevented insulin resistance and diet-induced obesity [10]; later work reported better physical performance at every age tested, with late-life intermittent dosing increasing capacity and healthspan [11].

Read the human half carefully. In a randomised acute-exercise study, 45 minutes of endurance cycling significantly raised circulating humanin — a related mitochondrial peptide — while MOTS-c rose only as a non-significant trend; resistance exercise moved neither. And at rest, circulating levels were not correlated with fitness: not VO2max, not strength, not muscle mitochondrial-DNA copy number [12]. A MOTS-c blood level is not a fitness gauge.

So: strong mouse results, a plausible mechanism, acute human signals exercise can nudge — and, to our knowledge, no completed human interventional trial showing that administered MOTS-c improves metabolic or health outcomes. The FDA lists compounded MOTS-c among bulk substances that may present significant safety risks, citing possible immunogenicity for certain routes and peptide-impurity concerns, with no human exposure data identified via any route (US framework; checked 13 October 2026) [13]. For transparency, two investigators on the key papers held shares and consultancy roles in a company developing mitochondrial peptides at the time of publication [11].

None of it supports the shortcut claim that a peptide could replace exercise or reverse ageing — no human evidence exists for either. MOTS-c research is a promising window into how exercise signals to metabolism: currently more valuable as science than as shopping. The full compound story is in our MOTS-c explainer (08).

Known limitations

• Trials cited range from eight sedentary men to a 5,973-participant synthesis; averaging hides individual variation.
• All fitness–mortality evidence is observational and single-centre, with selection bias.
• The MOTS-c interventions are animal studies; all percentages describe group averages, not individual outcomes.

FAQ

Does exercise really change mitochondria in older adults? Yes — measured trials show adults aged 65–80 improved aerobic capacity, mitochondrial respiration, insulin sensitivity and lean mass over 12 weeks [6]; the synthesis found adaptive capacity maintained throughout life [5].

Is HIIT better than steady training? Averaged gains were statistically indistinguishable across moderate, interval and sprint-style training; frequency and starting fitness dominate [5].

Do MOTS-c injections deliver those benefits? No completed human interventional trial shows that; the FDA flags safety unknowns for compounded MOTS-c, and the human data concern levels raised by one’s own exercise [12][13].

Where should an inactive beginner start? Build gradually — some activity is better than none — toward the WHO weekly target of 150–300 moderate minutes; with diabetes or heart disease, discuss starting with a qualified professional [9]; see the medical disclaimer.

Sources

1. Kelley DE, et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51(10):2944–2950. doi:10.2337/diabetes.51.10.2944 — https://pubmed.ncbi.nlm.nih.gov/12351431/
2. Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013;17(2):162–184. doi:10.1016/j.cmet.2012.12.012
3. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem. 1967;242(9):2278–82 — https://pubmed.ncbi.nlm.nih.gov/4290225/
4. Egan B, et al. Time course analysis reveals gene-specific transcript and protein kinetics of adaptation to short-term aerobic exercise training in human skeletal muscle. PLoS One. 2013;8(9):e74098. doi:10.1371/journal.pone.0074098
5. Mølmen KS, et al. Effects of exercise training on mitochondrial and capillary growth in human skeletal muscle: a systematic review and meta-regression. Sports Med. 2025;55(1):115–144. doi:10.1007/s40279-024-02120-2 — https://pubmed.ncbi.nlm.nih.gov/39390310/
6. Robinson MM, et al. Enhanced protein translation underlies improved metabolic and physical adaptations to different exercise training modes in young and old humans. Cell Metab. 2017;25(3):581–592. doi:10.1016/j.cmet.2017.02.009 — https://pubmed.ncbi.nlm.nih.gov/28273480/
7. Goodpaster BH, Sparks LM. Metabolic flexibility in health and disease. Cell Metab. 2017;25(5):1027–1036. doi:10.1016/j.cmet.2017.04.015
8. Mandsager K, et al. Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Netw Open. 2018;1(6):e183605. doi:10.1001/jamanetworkopen.2018.3605
9. Bull FC, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–1462. doi:10.1136/bjsports-2020-102955; WHO guideline page: https://www.who.int/publications/i/item/9789240015128/
10. Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. doi:10.1016/j.cmet.2015.02.009 — https://pubmed.ncbi.nlm.nih.gov/25738459/
11. Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12:470. doi:10.1038/s41467-020-20790-0
12. von Walden F, et al. Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans. J Appl Physiol. 2021;131(3):1035–1042. doi:10.1152/japplphysiol.00706.2019 — https://pubmed.ncbi.nlm.nih.gov/34351816/
13. US FDA. Certain bulk drug substances for use in compounding that may present significant safety risks — MOTS-c entry. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks (checked 13 October 2026; US framework)

Something wrong in this article? Send us a correction. Substantive changes are dated and logged.

Related reading

• Weight Loss and Muscle: Why Body Composition Matters — the lean-mass debates shaping the medication era, and why “muscle” and “lean mass” are not the same number. (07)
• MOTS-c Explained: Mitochondrial Science and the Human-Evidence Gap — the full compound story this article only sketches. (08)
• How to Read a Peptide Study Without Falling for the Hype — the study-reading toolkit behind every evidence boundary above. (02)

Newsletter

Want the next evidence check in your inbox? Subscribe to the research newsletter — brief, understandable research updates, fortnightly, one-click unsubscribe. No sales pitch for investigational compounds.

Suggest a correction